CASTLE BIOSCIENCES, INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
CASTLE BIOSCIENCES, INC. (CSTL) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of -$1.90 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-02-26
- CASTLE BIOSCIENCES, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was -$1.90M.
- CASTLE BIOSCIENCES, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was -$4.50M, a 188.24% decline from fiscal 2023.
- CASTLE BIOSCIENCES, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $5.10M, a 84.16% decline from fiscal 2022.
- CASTLE BIOSCIENCES, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $32.20M.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$1.90M 10-K · filed 2026-02-26 | |
| 2024-12-31 | -$4.50M 10-K · filed 2026-02-26 | |
| 2023-12-31 | $5.10M 10-K · filed 2026-02-26 | |
| 2022-12-31 | $32.20M 10-K · filed 2025-02-27 | -$1.63M 10-K · filed 2023-02-28 |
| 2021-12-31 | -$8.73M 10-K · filed 2023-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |